Please use this identifier to cite or link to this item:
http://nopr.niscpr.res.in/handle/123456789/63624| metadata.dc.identifier.doi: | https://doi.org/10.56042/ijeb.v62i04.655 |
| Title: | Role of cannabinoid CB1 receptors in the proconvulsant effect of Apelin-13 on penicillin-induced epileptiform activity |
| Authors: | Aycik, Fatma Banu Ayyildiz, Mustafa Agar, Erdal |
| Keywords: | Brain electrocorticograhy;Cannabinoid CB1 receptor agonists;Epilepsy;Neuromodulators |
| Issue Date: | Apr-2024 |
| Publisher: | NIScPR-CSIR, India |
| Abstract: | Epilepsy is a widespread neurological disorder. Many neurotransmitters, neuropeptides and neuromodulators have a significant role in the epileptic activity. Apelin-13 and cannabinoid CB1 receptor agonist and antagonist have an effect in the penicillin model of epilepsy. The relationship between apelin and epilepsy, and the apelin-cannabinoid relationship in epilepsy is still not well understood. Thus, this study focuses on the relationship between apelin-13 and CB1 receptor in experimental model of epilepsy. Penicillin injection was given intracortically (i.c.) for the development of epileptic seizures. Ninety-one male Wistar rats were divided into 13 groups. CB1 receptor agonist ACEA (7.5 μg, intracerebroventricularly, icv) and antagonist AM-251 (0.25 μg and 0.125 μg, icv) were administered to three different groups, two different doses of apelin-13 (5 μg and 15 μg, icv) were applied and the interactions between these five groups of substances were evaluated. Both apelin-13 (15 μg) and AM-251 (0.25 μg) raised the spike frequency of epileptiform activity separately. Application of apelin-13 + AM-251 also increased the spike frequency of epileptiform activity beginning in the 30 min after apelin-13 application. When the non-effective dose of AM-251 and the effective dose of apelin-13 were administered together, epileptic activity increased in the 20 min. ACEA reduced the epileptiform activity starting in the 50th min. apelin-13 and ACEA administration in effective doses decreased epileptiform activity. The non-effective doses of AM-251, apelin-13 and effective dose of ACEA decreased the epileptiform activity in the 50 min. Application of non-effective doses of apelin and AM-251 together does not induce any additional proconvulsant activity, and CB1 receptor agonist, ACEA reversed the proconvulsant activity of apelin-13. These results suggest that they utilize different receptors to begin their own effects by increasing intracellular Ca2+ in epilepsy. Considering that apelin-13 is an endogenous substance known for its neuroprotective properties, the proconvulsant effect of apelin-13 in the presented study is remarkable. |
| Page(s): | 238-244 |
| ISSN: | 0975-1009 (Online); 0019-5189 (Print) |
| Appears in Collections: | IJEB Vol.62(04) [April 2024] |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| IJEB Vol. 62 (04) 238-244.pdf | 944.06 kB | Adobe PDF | View/Open | |
| IJEB Vol. 62 (04) 238-244 Suppl.pdf | 390.22 kB | Adobe PDF | View/Open |
Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.